|Articles|April 1, 2006

Pharmacy Times

  • Volume 0
  • 0

LOW-DOSE VITAMIN K DECREASES INR FLUCTUATION

Patients who experiencelarge fluctuations in theirinternational normalized ratio(INR) measurement may benefitfrom supplementationwith low-dose vitamin K. Asmall study of 8 highly motivated,adherent patients whowere experiencing significantchanges in their INR for no identifiable reasonbegan taking 100 μg of vitamin K daily,similar to the usual daily vitamin K intakein the United States (60-90 μg).They beganthis therapy with the knowledge of theiranticoagulation provider, and only whentheir INR was elevated or not significantlybelow their INR target.

The absolute number of INRs increasedin range from 18% to 42%after supplementation. Onlyone patient failed to achievebetter INR control. (Thispatient had lupus anticoagulant,which is known tointerfere with INR measurements.)The authors concludedthat these resultswarrant further study of the use of vitaminK for INR stabilization.

Patients who are selected for this therapyneed to be monitored very carefully,as the INR may drop substantially duringthe initial 1 to 2 weeks of treatment.Patients should never begin vitamin Ksupplementation without the approval oftheir anticoagulation provider.

Dr. Garrett is a clinical pharmacistpractitioner at Cornerstone HealthCare in High Point, NC.

Articles in this issue

over 19 years ago

Pharmacists—Cops or Not? (Part 2)

over 19 years ago

canyouREADtheseRxs?

over 19 years ago

compoundingHOTLINE

over 19 years ago

NSAIDs and Antihypertensive Agents

over 19 years ago

FDA Approves New Constipation Drug

over 19 years ago

Angina Drug Approved

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME